Efficacy, safety and tolerability of Tesaglitazar therapy when added to the therapy of patients with Type 2 Diabetes poorly controlled on Sulphonylurea alone

  • Simpson, Richard (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/04 → 30/06/05